<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F9308141-E02E-47A0-820B-09C0A032DE01"><gtr:id>F9308141-E02E-47A0-820B-09C0A032DE01</gtr:id><gtr:name>Bioquell UK Limited</gtr:name><gtr:address><gtr:line1>52 ROYCE CLOSE , WEST PORTWAY</gtr:line1><gtr:city>ANDOVER</gtr:city><gtr:postCode>SP10 3TS</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F9308141-E02E-47A0-820B-09C0A032DE01" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>F9308141-E02E-47A0-820B-09C0A032DE01</gtr:id><gtr:name>Bioquell UK Limited</gtr:name><gtr:address><gtr:line1>52 ROYCE CLOSE , WEST PORTWAY</gtr:line1><gtr:city>ANDOVER</gtr:city><gtr:postCode>SP10 3TS</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>30802.0</gtr:offerGrant><gtr:projectCost>51337.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B67A56C4-4375-4A60-96AC-A98CE60B0DB4"><gtr:id>B67A56C4-4375-4A60-96AC-A98CE60B0DB4</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Chewins</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=132185"><gtr:id>4DA13251-D77D-4941-83D1-4E30BCD61818</gtr:id><gtr:title>Evaluating the efficacy of H2O2 vapour against biofilms formed by multi-drug resistant organisms (MDROs</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>132185</gtr:grantReference><gtr:abstractText>The project aims to evaluate the efficacy of Bioquell's 35% hydrogen peroxide vapour (HPV) technology against

single and multi-species biofilms, produced by multi-drug resistant organisms (MDROs) associated with hospital

acquired infection. Recent evidence shows that biofilms can survive in excess of 12 months on surfaces within

hospital rooms, even after terminal cleaning with bleach. It is believed that these biofilms act as reservoirs for

infection, with the potential to contaminate patients who come into contact with them. Bioquell is working in

conjunction with University of Southampton.</gtr:abstractText><gtr:fund><gtr:end>2017-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>30802</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">132185</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>